Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0RP0X | ISIN: US45822R1014 | Ticker-Symbol: N/A
Frankfurt
17.05.24
08:01 Uhr
0,143 Euro
0,000
0,00 %
1-Jahres-Chart
INTELGENX TECHNOLOGIES CORP Chart 1 Jahr
5-Tage-Chart
INTELGENX TECHNOLOGIES CORP 5-Tage-Chart

Aktuelle News zur INTELGENX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.08.IntelGenx Technologies Corp. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB14
23.07.IntelGenx Technologies Corp. - 8-K, Current Report7
19.07.IntelGenx Technologies Corp.: IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process377MONTREAL, July 19, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the "Company" or "IntelGenx") (OTC: IGXT), a leading drug delivery company focused on the development and manufacturing of...
► Artikel lesen
03.07.IntelGenx Technologies Corp.: IntelGenx Obtains Preliminary Efficacy Results for the 'BUENA' Montelukast VersaFilm Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease310MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the "Company" or "IntelGenx" a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA...
► Artikel lesen
28.06.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.06.20242.839The following instruments on Boerse Frankfurt do have their last trading day on 28.06.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.06.2024ISIN NameAU000000GUD2 G.U.D....
► Artikel lesen
INTELGENX Aktie jetzt für 0€ handeln
11.06.IntelGenx Technologies Corp: IntelGenx receives CCAA protection order, begins SISP7
11.06.IntelGenx Technologies Corp.: IntelGenx Announces Initiation of the Sale and Investment Solicitation Process192MONTREAL, June 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the "Company" or "IntelGenx" a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), was granted protection pursuant to...
► Artikel lesen
07.06.IntelGenx Technologies Corp. - 8-K, Current Report5
28.05.IntelGenx Technologies Corp: IntelGenx Technologies to be delisted from TSX June 274
28.05.IntelGenx Technologies Corp: IntelGenx receives court approval to seek company sale2
28.05.IntelGenx Technologies Corp.: IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation Process277MONTREAL, May 28, 2024 (GLOBE NEWSWIRE) -- As previously announced on May 17, 2024, IntelGenx Technologies Corp. (the "Company" or "IntelGenx") (OCTQB: IGXT; TSX: IGX), a leading drug delivery company...
► Artikel lesen
17.05.IntelGenx Technologies Corp.: IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives285MONTREAL, May 17, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the "Company" or "IntelGenx") (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing...
► Artikel lesen
17.05.XFRA 0IL: AUSSETZUNG/SUSPENSION374DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILINTELGENX TECHN.DL-...
► Artikel lesen
08.04.IntelGenx Technologies Corp.: IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm in Phase 2 'MONTPARK' Clinical Trial136SAINT LAURENT, Quebec, April 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Montelukast VersaFilm® has been administered to...
► Artikel lesen
05.04.IntelGenx Technologies Corp.: IntelGenx Updates Status of Buprenorphine Buccal Film ANDA183SAINT LAURENT, Quebec, April 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that its co-developer, Chemo Research SL, through its...
► Artikel lesen
21.03.IntelGenx Technologies Corp.: IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results147SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and twelve-month...
► Artikel lesen
18.12.23IntelGenx Technologies Corp.: IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm332SAINT LAURENT, Quebec, Dec. 18, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into development and license agreements...
► Artikel lesen
28.11.23IntelGenx Technologies Corp.: IntelGenx Announces Shareholder Approval of Financing Transactions262SAINT LAURENT, Quebec, Nov. 28, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) ("IntelGenx" or the "Company") is pleased to announce that, at its meeting held earlier...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
Verkaufen HaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1